Your browser doesn't support javascript.
loading
Detection of minimal residual disease by next generation sequencing in AL amyloidosis.
Sarosiek, Shayna; Varga, Cindy; Jacob, Allison; Fulciniti, Maria Teresa; Munshi, Nikhil; Sanchorawala, Vaishali.
Affiliation
  • Sarosiek S; Section of Hematology & Medical Oncology, Boston Medical Center, Boston, MA, USA.
  • Varga C; Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA.
  • Jacob A; The John C Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA, USA.
  • Fulciniti MT; Division of Hematology-Oncology, Tufts Medical Center, Boston, MA, USA.
  • Munshi N; Adaptive Biotechnologies, Seattle, WA, USA.
  • Sanchorawala V; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA.
Blood Cancer J ; 11(6): 117, 2021 06 21.
Article in En | MEDLINE | ID: mdl-34155198
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: High-Throughput Nucleotide Sequencing / Flow Cytometry / Immunoglobulin Light-chain Amyloidosis Type of study: Diagnostic_studies Limits: Female / Humans / Male Language: En Journal: Blood Cancer J Year: 2021 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: High-Throughput Nucleotide Sequencing / Flow Cytometry / Immunoglobulin Light-chain Amyloidosis Type of study: Diagnostic_studies Limits: Female / Humans / Male Language: En Journal: Blood Cancer J Year: 2021 Document type: Article Affiliation country: United States